Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Rockwell Automation Announces Dividend Distribution and Yield Comparison

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Technology Data analytics Stock Bull Market
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Rockwell Automation (NYSE: ROK) is set to distribute a dividend of $1.25 per share on March 11, 2024, boasting an annualized dividend yield of 1.92%. Investors who held the stock before the ex-dividend date of February 16, 2024, will be eligible for the payout.

The company has a track record of steady dividend payments, maintaining a sustainable payout ratio of 41.52%. This consistency in dividends makes Rockwell Automation an appealing choice for investors seeking income. Furthermore, Rockwell Automation outperforms its industry peers in terms of dividend yield, with Emerson Electric trailing behind at 1.91%.

For those interested in investing in Rockwell Automation, monitoring its dividend history and payout schedule can offer valuable insights into the company’s financial stability and long-term performance.

Emerson Electric Co. (EMR) Stock Performance Declines Slightly on March 11, 2024 – Investors Monitor Price Momentum for Future Shifts

On March 11, 2024, Emerson Electric Co. (EMR) experienced a slight decrease in its stock performance. The stock opened at $109.48, which was $0.67 lower than its previous close. Throughout the trading day, the price of EMR shares continued to decline, ultimately decreasing by $0.79 or 0.72% by the time the market closed.

Investors may be keeping a close eye on EMR’s price momentum, as it could potentially signal a shift in the stock’s performance in the near future. While the decrease on March 11 may be a cause for concern for some investors, it is important to consider the overall trend of the stock and its performance over a longer period of time.

EMR Stock Performance Analysis: Total Revenue, Net Income, and EPS Decline in Latest Financial Results

On March 11, 2024, EMR stock performance was under scrutiny as the company released its financial results for the past year and the first quarter of the current year. According to data from CNN Money, EMR reported total revenue of $15.17 billion for the past year, which decreased by 22.73% compared to the previous year. The total revenue for the first quarter of the current year was $4.12 billion, which remained flat compared to the previous quarter.

The net income for EMR was reported as -$174.00 million for the past year, showing a decrease of 105.39% compared to the previous year. The net income for the first quarter of the current year was $142.00 million, which decreased by 79.74% compared to the previous quarter.

Earnings per share (EPS) for EMR were reported as -$0.30 for the past year, showing a decrease of 105.59% compared to the previous year. The EPS for the first quarter of the current year was $0.25, which decreased by 79.95% compared to the previous quarter.

These financial results indicate a challenging year for EMR, with significant decreases in total revenue, net income, and earnings per share. Investors and analysts will be closely monitoring the company’s performance in the coming quarters to see if there are any signs of improvement or if the downward trend continues.

Tags: EMR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Automotive Stock Market Today

RBC Capital Maintains Sector Perform Rating and 15 Price Target for Rivian Automotive

Food Retailers Stock Market Today

DA Davidson Analyst Reaffirms Buy Rating on Campbell Soup with Lowered Price Target

Finance_Business (2)

Analyst Michael Mueller Reaffirms Neutral Rating on Americold Realty Trust with Revised Price Target

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com